Live Breaking News & Updates on Leede jones gab

Stay updated with breaking news from Leede jones gab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

FY2023 EPS Estimates for Quipt Home Medical Corp. Raised by Leede Jones Gab (NASDAQ:QIPT)

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

United-states , Canada , America , Raymond-james , Leede-jones-gab , Quipt-home-medical-corp , America-corp , Nasdaq , Marshall-wace , Quipt-home-medical-company-profile-get-rating , Acadian-asset-management , Citadel-advisors

Short Interest in Oncolytics Biotech Inc. (NASDAQ:ONCY) Rises By 22.3%

Oncolytics Biotech Inc. (NASDAQ:ONCY – Get Rating) was the recipient of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 213,100 shares, an increase of 22.3% from the May 15th total of 174,300 shares. Based on an average trading volume of 132,300 shares, the […]

Canada , Leede-jones-gab , Oncolytics-biotech-inc , Geode-capital-management , Oncolytics-biotech , Dimensional-fund-advisors , Nasdaq , Royal-bank , Get-rating , Jones-gab , Fund-advisors , Capital-management

Oncolytics Biotech (TSE:ONC) Sets New 52-Week Low at $1.22

Shares of Oncolytics Biotech Inc. (TSE:ONC – Get Rating) reached a new 52-week low on Monday . The stock traded as low as C$1.22 and last traded at C$1.29, with a volume of 46352 shares changing hands. The stock had previously closed at C$1.33. Several research firms have recently weighed in on ONC. Leede Jones […]

Leede-jones-gab , Oncolytics-biotech-inc , Oncolytics-biotech , Oncolytics-biotech-company-profile , Get-rating , Jones-gab , Biotech-company-profile , Biotech-inc , Tse-onc , Onc , Medical , Stocks

Quipt Home Medical Corp. (NASDAQ:QIPT) Expected to Post FY2022 Earnings of $0.19 Per Share

Quipt Home Medical Corp. (NASDAQ:QIPT – Get Rating) – Equities research analysts at Leede Jones Gab increased their FY2022 earnings estimates for shares of Quipt Home Medical in a report released on Tuesday, May 17th. Leede Jones Gab analyst D. Loe now forecasts that the company will post earnings of $0.19 per share for the […]

Boston , Massachusetts , United-states , Manhattan , New-york , Canada , Raymond-james , Leede-jones-gab , Quipt-home-medical-corp , Russell-investments-group-ltd , Zacks-investment-research , First-manhattan-co

Sernova Corp. Expected to Post FY2024 Earnings of ($0.02) Per Share (CVE:SVA)

Sernova Corp. (CVE:SVA – Get Rating) – Equities researchers at Leede Jones Gab issued their FY2024 earnings estimates for shares of Sernova in a note issued to investors on Tuesday, May 17th. Leede Jones Gab analyst D. Loe anticipates that the company will post earnings per share of ($0.02) for the year. Leede Jones Gab […]

Canada , Leede-jones-gab , Sernova-corp , Get-rating , Jones-gab , Echelon-wealth-partners , Cell-pouch , Sernova , Cve-sva , Sva , Medical , Earnings-estimates

FY2022 EPS Estimates for Quipt Home Medical Corp. Cut by Leede Jones Gab (CVE:QIP)

Quipt Home Medical Corp. (CVE:QIP – Get Rating) – Equities research analysts at Leede Jones Gab cut their FY2022 earnings per share estimates for shares of Quipt Home Medical in a report released on Tuesday, April 19th. Leede Jones Gab analyst D. Loe now anticipates that the company will earn $0.06 per share for the […]

Leede-jones-gab , Quipt-home-medical-corp , Quipt-home-medical , Get-rating , Jones-gab , Home-medical , Cve-qip , Qip , Cve , Earnings-estimates ,

Analysts Expect Oncolytics Biotech Inc. (NASDAQ:ONCY) Will Announce Earnings of -$0.20 Per Share

Equities analysts expect Oncolytics Biotech Inc. (NASDAQ:ONCY – Get Rating) to post earnings per share of ($0.20) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Oncolytics Biotech’s earnings. Oncolytics Biotech posted earnings of ($0.10) per share during the same quarter last year, which would indicate a negative […]

Leede-jones-gab , Morgan-stanley , Oncolytics-biotech-inc , Long-focus-capital-management , Zacks-investment-research , Renaissance-technologies , Advisor-resource-council , Nasdaq , Oncolytics-biotech , Canaccord-genuity-group , Citadel-advisors , Get-rating

Analysts Issue Forecasts for Centric Health Corp.'s FY2023 Earnings (TSE:CRX)

Centric Health Corp. (TSE:CRX – Get Rating) – Stock analysts at Cormark issued their FY2023 earnings estimates for Centric Health in a research note issued to investors on Monday, March 21st. Cormark analyst K. Mcphee expects that the company will earn $0.38 per share for the year. CRX has been the topic of several other […]

Leede-jones-gab , Centric-health-corp , Centric-health , Get-rating , Jones-gab , Tse-crx , Crx , Tse , Earnings-estimates , Cormark ,

Centric Health Corp. (TSE:CRX) to Post FY2022 Earnings of $0.03 Per Share, Cormark Forecasts

Centric Health Corp. (TSE:CRX – Get Rating) – Cormark issued their FY2022 earnings estimates for Centric Health in a research report issued on Monday, March 21st. Cormark analyst K. Mcphee forecasts that the company will post earnings of $0.03 per share for the year. Cormark also issued estimates for Centric Health’s FY2024 earnings at $0.52 […]

Leede-jones-gab , Centric-health-corp , Centric-health , Get-rating , Jones-gab , Tse-crx , Crx , Tse , Earnings-estimates , Cormark ,